To determine whether the recruitment of Pontin/Reptin by E2f1 also occurs in the context of human disease, we repeated the pull-down fraction of E2f1 in three different human HCC (hHCC) cell lines. This evidence concerns the gene RUVBL2 and hepatocellular carcinoma.